Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
3,203
Views
5
CrossRef citations to date
0
Altmetric
Methods & Modeling
A comparison of mixture cure fraction models to traditional parametric survival models in estimation of the cost-effectiveness of nivolumab for relapsed small cell lung cancer
Joshua A. Rotha Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USACorrespondence[email protected]
https://orcid.org/0000-0001-6621-8342
Yong Yuanb Global Health Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA
, Megan Othusa Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
, Mark Danesec HEOR, Outcomes Insights, Westlake Village, CA, USA
https://orcid.org/0000-0002-7068-9603
Samuel Wagnerb Global Health Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA
, John R. Penrodb Global Health Outcomes, Bristol-Myers Squibb, Princeton, NJ, USA
& Scott D. Ramseya Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
show all
Pages 79-86
|
Received 18 Jun 2020, Accepted 20 Nov 2020, Published online: 11 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.